Skip to content
Recall Observatory FDA recall evidence

Drug product

Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.

D-1876-2019

September 06, 2019

Class II

Product summary

Firm
Cardinal Health dba Specialty Pharmaceutical Services
Event
Event 83731
Status
Terminated
Classification
Class II
Quantity
38 syringes
Official record key
drug-enforcement:D-1876-2019

Official wording

Reason: Temperature Abuse; Product stored and shipped outside of labeled storage requirements.

Code information: Lot #: S25X, Exp. 03/31/21

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Temperature Abuse; Product stored and shipped outside of labeled storage requirements.